MYGN Nov 2024 23.000 put
| Previous Close | 1.3000 |
| Open | 1.3000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 23.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 1.3000 - 1.4000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
GlobeNewswireMyriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a national organization that delivers education and access to preventative genetic testing with a focus on high-risk populations. The collaboration combines the strengths of Myriad’s high-quality hereditary cancer and reproductive genetics products, MyRisk® with RiskScore® and Foresight® Carrier Screen, w
- GlobeNewswire
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration
Myriad’s MyRisk® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR® SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with Flatiron Health, a leading health tech company dedicated to expanding the possibilities of point of care solutions in oncology. This collaboration allows physicians to order Myriad’s MyRisk® Hereditary Cancer Test and view the re
Simply Wall St.Myriad Genetics (NASDAQ:MYGN) shareholders are still up 61% over 1 year despite pulling back 7.9% in the past week
It might be of some concern to shareholders to see the Myriad Genetics, Inc. ( NASDAQ:MYGN ) share price down 13% in...
